Articles:
After assisting in the development of a pre-fabricated node module for Heathrow Terminal 5, he took on a new role in the company developing innovative design solutions utilising BIM and.
Global deployment of SARS-CoV-2 vaccines within a year.. Development of mRNA vaccines targeting previously untreatable diseases like cancer and autoimmune disorders, expected to be available by 2030..Significant increase in the approval and use of advanced therapy medicinal products (ATMPs) such as cell and gene therapies, which were introduced just 14 years ago.. 400 times increase in FDA clinical trials for new drugs in the past two decades..
Rapid expansion of bio-revolution into various sectors like agriculture, consumer goods, bio-services, bio-computing, bio-informatics, and bio-industry..These advancements, combined with broader societal, political, and economic trends, are projected to double the size of the life science market within the next decade..The challenge: exponential demand, high complexity, & lagging supply.
Laboratories support all stages of the life science value-chain, from R&D to manufacturing and diagnostics, and exponential market growth means exponential demand for lab space..In addition to this rising demand, life science businesses and developers looking to deploy labs face additional challenges, including:.
A lack of existing lab space in some locations already today.
In Cambridge and Oxford for example (two of the UK’s main life science hubs), demand for labs now outstrips available supply by nearly a hundred to one.and manufactured elements.
It allows clients to maintain control over intellectual property and incorporate lessons learned to improve design cycles.Multiple uses refine the design, enhancing layouts, space allocation, and functional flows.. Configuring Reference Design.
Chip Thinking® lends itself to the use of digital configurators, automating the design process.These tools quickly generate compliant design options, enabling clients to make informed decisions rapidly.